Welcome to LookChem.com Sign In|Join Free
  • or
(3,3-Difluoropyrrolidin-1-yl)[(2S,4S)-4-[4-(pyrimidin-2-yl)piperazin-1-yl]pyrrolidin-2-yl]methanone is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

869490-23-3

Post Buying Request

869490-23-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

869490-23-3 Usage

Uses

Gosogliptin is used as a treatment for type 2 diabetes.

Check Digit Verification of cas no

The CAS Registry Mumber 869490-23-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,9,4,9 and 0 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 869490-23:
(8*8)+(7*6)+(6*9)+(5*4)+(4*9)+(3*0)+(2*2)+(1*3)=223
223 % 10 = 3
So 869490-23-3 is a valid CAS Registry Number.

869490-23-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name (3,3-difluoropyrrolidin-1-yl)-[(2S,4S)-4-(4-pyrimidin-2-ylpiperazin-1-yl)pyrrolidin-2-yl]methanone

1.2 Other means of identification

Product number -
Other names UNII-GI718UO477

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:869490-23-3 SDS

869490-23-3Downstream Products

869490-23-3Relevant academic research and scientific papers

New synthetic route to a dipeptidyl peptidase-4 inhibitor

Lafrance, Danny,Caron, Stephane

, p. 409 - 414 (2012/07/31)

A new synthetic route to a dipeptidyl peptidase-4 (DPP4) inhibitor was developed and demonstrated on a multigram scale. This approach takes advantage of the cheap and readily available Boc-trans-4-hydroxy-l-proline methyl ester as starting material which

Therapeutic compounds

-

Page/Page column 18-19, (2008/06/13)

The invention provides compounds of formula (I), prodrugs and stereoisomers thereof, and the pharmaceutically acceptable salts of the compounds, prodrugs, and stereoisomers, wherein R1, R2, R3, HET, n, Q, X, Y, and Z are as described herein; compositions thereof; and uses thereof in treating diabetic complications including diabetic neuropathy, diabetic nephropathy, diabetic microangiopathy, and the like.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 869490-23-3